Congress creates men's health office, but funds it by cutting women's health budgets

What it does

This bill directs the Department of Health and Human Services to commission a study on men's health disparities and establish a new Office of Men's Health within 18 months to coordinate federal programs, promote awareness, and research men's health issues—particularly prostate cancer, colorectal cancer, diabetes, and mental health. The bill funds these activities from existing HHS budgets, not new appropriations.

Why we flagged it

The bill's core function is establishing a federal office to study, coordinate, and promote awareness of men's health disparities and preventive care. It is a public-health infrastructure bill, not a clinical intervention or funding expansion.

What the text implies

• The bill explicitly excludes funding from women's health offices (section 4, final sentence), creating a potential budget conflict and signaling a zero-sum framing of gender-specific health priorities rather than integrated public health.
• Establishing a separate men's health office may duplicate or fragment coordination efforts already underway in disease-specific offices (cancer, diabetes, mental health), potentially creating bureaucratic silos rather than improving efficiency.
• The GAO study and Office activities focus on 'male engagement in the health care system' but do not address root causes of health disparities (socioeconomic, occupational, behavioral, or access barriers), potentially limiting the effectiveness of awareness-only interventions.

Who it affects

The bill addresses a documented public-health gap: men die earlier and at higher rates than women from preventable causes, and increased awareness and screening could save lives. However, the bill creates a parallel bureaucratic structure that may fragment rather than integrate men's and women's health efforts, and the funding mechanism (drawing from existing women's health budgets) creates a zero-sum trade-off that could weaken overall gender-inclusive health coordination.

Who stands to gain

• health insurance companies (increased screening and preventive care utilization)
• pharmaceutical companies (increased diagnosis and treatment of chronic diseases)
• healthcare providers and hospital systems (increased patient engagement and screening volume)

Named in the bill

Department of Health and Human Services, Office of Men's Health, Office on Women's Health, Comptroller General, Centers for Disease Control and Prevention, National Cancer Institute, Social Security Administration

Where it stands

16 cosponsors: 8 Democrats, 8 Republicans.

• Feb 20, 2026 — Introduced · Congress.gov: “Introduced in House”
• Feb 20, 2026 — Referred to House Committee on Energy and Commerce · Congress.gov: “Referred to the House Committee on Energy and Commerce”

Dates and quoted wording are Congress.gov's action record; the timeline shows status changes, not every procedural step.

Money around this bill

2 lobbying clients named this bill on 2 disclosure filings across 1 quarter, Jun 2026 to Jun 2026. Those filings disclosed $163,655 in lobbying spend. A filing names 2 bills on average, so that figure is what each filing reported, not a share belonging to this bill.

More lobbying clients named this bill than 41% of bills with at least one filing.

Troy Carter, the sponsor, reported $1,021,748 in PAC receipts in the 2026 cycle.

• Zero Prostate Cancer — $123,655 on 1 filing
• American Urological Association — $40,000 on 1 filing

Lobbying Disclosure Act filings through Jul 20, 2026. A filing shows who paid to lobby on a bill it names, not what changed.